SCHEMBL3307110

SCHEMBL3307110

CC(=O)c1ccc(OCc2ccccc2)c2ncccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
KDM4E B2RXH2 2/20 0.51
MAOB P27338 1/20 0.49
SLC40A1 Q9NP59 1/20 0.48
PDE4A P27815 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
EGLN1 Q9GZT9 1/20 0.46
PPIA P62937 1/20 0.46
TSHR P16473 1/20 0.45
CASP3 P42574 1/20 0.45
RAB9A P51151 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30147524 0.83 MAPT (0.65) MAPTSMN1; SMN2L3MBTL1TDP1CYP2C9
SCHEMBL18428699 0.83 MAPT (0.65) MAPTSMN1; SMN2L3MBTL1TDP1CYP2C9
SCHEMBL16407670 0.79 PSMD14 (0.53) MAPTSMN1; SMN2L3MBTL1TDP1KDM4E
SCHEMBL28594857 0.78 LIPE (0.55) MAPTSMN1; SMN2L3MBTL1TDP1KDM4E
SCHEMBL10333926 0.78 KDM4E (0.57) MAPTSMN1; SMN2L3MBTL1TDP1KDM4E
SCHEMBL24303045 0.76 CA9 (0.52) MAPTSMN1; SMN2L3MBTL1TDP1CYP2C9
SCHEMBL3976299 0.76 KDM4E (0.63) MAPTSMN1; SMN2L3MBTL1TDP1KDM4E
SCHEMBL29862716 0.76 SLC40A1 (0.50) MAPTSMN1; SMN2L3MBTL1TDP1KDM4E
SCHEMBL13625118 0.76 SLC40A1 (0.50) MAPTSMN1; SMN2L3MBTL1TDP1KDM4E
SCHEMBL6600225 0.76 LTA4H (0.58) MAPTSMN1; SMN2L3MBTL1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132179-B1 PROCESS FOR PREPARING ISOMERS OF CARMOTEROL CIPLA LTD (IN) 2012-08-08 EP disclosed
US-8236959-B2 Process for preparing isomers of carmoterol CIPLA LIMITED (IN) 2012-08-07 US disclosed
US-8236959-B2 Process for preparing isomers of carmoterol CIPLA LIMITED (IN) 2012-08-07 US disclosed
US-8236959-B2 Process for preparing isomers of carmoterol CIPLA LIMITED (IN) 2012-08-07 US disclosed
US-20100113790-A1 Process for Preparing Isomers of Carmoterol CIPLA LIMITED (IN) 2010-05-06 US disclosed
US-20100113790-A1 Process for Preparing Isomers of Carmoterol CIPLA LIMITED (IN) 2010-05-06 US disclosed
US-20100113790-A1 Process for Preparing Isomers of Carmoterol CIPLA LIMITED (IN) 2010-05-06 US disclosed
EP-2132179-A1 PROCESS FOR PREPARING ISOMERS OF CARMOTEROL Cipla Limited (IN) 2009-12-16 EP disclosed
WO-2008104781-A1 PROCESS FOR PREPARING ISOMERS OF CARMOTEROL CIPLA LIMITED (IN) 2008-09-04 WO disclosed
WO-2008104781-A1 PROCESS FOR PREPARING ISOMERS OF CARMOTEROL CIPLA LIMITED (IN) 2008-09-04 WO disclosed
US-RE33024-E Bronchodilating 8-hydroxy-5-(1R)-1-hydroxy-2-(N-((1R)-2-(p-methoxyphenyl)-1-methylethyl)-amino)ethyl) carbostyril and intermediates thereof TANABE SEIYAKU CO. LTD. (JP) 1989-08-15 US disclosed
EP-0147719-B1 NOVEL CARBOSTYRIL DERIVATIVE AND PROCESS FOR PREPARING SAME Tanabe Seiyaku Co., Ltd. (JP) 1989-07-26 EP disclosed
US-4579854-A ADRENERGIC STIMULANTS TANABE SEIYAKU CO., LTD. (JP) 1986-04-01 US disclosed
EP-0147719-A2 Novel carbostyril derivative and process for preparing same Tanabe Seiyaku Co., Ltd. (JP) 1985-07-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113790-A1 Process for Preparing Isomers of Carmoterol NR1H2, NR1H3, ADRB1 MAPT 4670/4885SMN1; SMN2 3364/4885L3MBTL1 3757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.